z-logo
Premium
Radiosynthesis and preliminary biodistribution in mice of 6‐deoxy‐6‐[ 131 I]iodo‐ L ‐ascorbic acid
Author(s) -
Kim Jintaek,
Yamamoto Fumihiko,
Karasawa Satoru,
Mukai Takahiro,
Maeda Minoru
Publication year - 2009
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.1610
Subject(s) - ascorbic acid , chemistry , radiosynthesis , biodistribution , iodine , radiochemistry , bromine , iodide , in vivo , chromatography , nuclear chemistry , biochemistry , organic chemistry , in vitro , food science , microbiology and biotechnology , biology
An ascorbate analog labeled with iodine‐131, 6‐deoxy‐ 6‐[ 131 I]iodo‐ L ‐ascorbic acid was prepared for evaluation as an in vivo tracer of L ‐ascorbic acid. The no‐carrier‐added radiosynthesis was conducted by nucleophilic bromine–iodine exchange between the brominated precursor and sodium [ 131 I]iodide in 2‐pentanone at 130–140°C. HPLC purification using a reverse‐phase column gave 6‐deoxy‐6‐[ 131 I]iodo‐ L ‐ascorbic acid in radiochemical yield of 36–60% with high radiochemical purity and satisfactory‐specific radioactivity in a total preparation time of 90 min. Biodistribution studies in fibrosarcoma‐bearing mice showed a high uptake in the adrenal glands, accompanied by low activity of tumor accumulation, accumulation properties similar to previous results obtained with 14 C‐labeled ascorbic acid and 6‐deoxy‐6‐[ 18 F]fluoro‐ L ‐ascorbic acid, in spite of high level of deiodination. Copyright © 2009 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom